Blab Business
IKS Health Reports 21% Revenue Growth and 28% PAT Increase in Q1 FY27
In a robust start to fiscal 2027, IKS Health – the healthcare‑technology arm of Inventurus Knowledge Solutions – announced first‑quarter results that outpaced market expectations, posting a 21% jump in revenue and a 28% lift in profit after tax.
The company, listed on the National Stock Exchange and the Bombay Stock Exchange under the ticker IKS, reported revenue of INR 8,936 million for the quarter ended 30 June 2026. That figure represents a 20.7% year‑over‑year rise and translates into a 12% increase when measured in U.S. dollars, underscoring sustained demand for its AI‑driven revenue‑cycle management solutions.
Profit after tax (PAT) climbed to INR 1,937 million, a 27.8% YoY gain that left PAT as 21.7% of revenue. Adjusted PAT, which excludes one‑off items, reached INR 2,153 million – a 28.0% YoY increase – and stood at 24.1% of revenue.
“We’ve delivered a solid first quarter that demonstrates the resilience of our business model, built on strong client trust, operational efficiency, and a scalable care‑enablement platform,” said Sachin K. Gupta, Founder and Global CEO of IKS Health. Gupta added that the recent acquisition of TruBridge, a rural‑hospital‑focused provider of electronic‑health‑record and revenue‑cycle services, expands the company’s capabilities and deepens its reach into community hospitals.
Group Chief Financial Officer Nithya Balasubramanian highlighted the role of disciplined cost management and capital efficiency in driving the results. “We closed Q1 FY27 with robust financial results, delivering 21% YoY revenue growth and a 28% YoY increase in PAT. Our priority for the remainder of the fiscal year remains clear: protecting our margins while investing prudently in strategic capabilities that secure long‑term value,” she said.
Key financial highlights for the quarter were:
Revenue: INR 8,936 million, up 20.7% YoY EBITDA: INR 2,949 million, 33% of revenue, up 24% YoY PAT: INR 1,937 million, 21.7% of revenue, up 27.8% YoY Adjusted PAT: INR 2,153 million, 24.1% of revenue, up 28.0% YoY
In addition to the numbers, IKS Health earned several industry recognitions. A U.S. patent was granted for its proprietary Engagement Learning Engine, an AI‑driven “Awareness‑Ability‑Willingness” behavioral model that powers patient‑access solutions such as MyCareHub. The company was named a Titan CEO in the 2026 Dallas‑Fort Worth Titan 100 list, and its CFO, Nithya Balasubramanian, received the Best CFO in Healthcare award at the 2026 CFO & Finance Strategy Excellence Awards. IKS Health also earned the FE HR Award for Excellence in Onboarding and Role Enablement and the American Medical Group Association Distinguished Corporate Partner Award.
The acquisition of TruBridge closed on 9 July 2026 for $557 million, following an announcement in April 2026. The deal brings TruBridge’s rural‑hospital‑focused electronic‑health‑record and revenue‑cycle capabilities into IKS Health’s AI‑powered platform, allowing the company to expand its service footprint and deepen relationships with community hospitals.
With a 46% compound annual growth rate in PAT over the past decade, IKS Health’s latest results reinforce its trajectory of profitable growth. Investors and analysts will be watching the company’s performance in the remaining quarters of FY27, its ability to integrate TruBridge’s operations, and its continued expansion into rural and community health systems.
IKS Health’s CEO reiterated a focus on margin protection while investing in strategic capabilities that secure long‑term value. The next earnings release is expected in the fourth quarter of FY27, where analysts will look for continued revenue growth, margin stability, and the impact of the TruBridge integration.
In summary, IKS Health reported strong first‑quarter results, highlighted by significant revenue and PAT growth, a successful acquisition that expands its rural‑hospital footprint, and several industry awards that underscore its leadership in AI‑driven healthcare solutions.
The company, listed on the National Stock Exchange and the Bombay Stock Exchange under the ticker IKS, reported revenue of INR 8,936 million for the quarter ended 30 June 2026. That figure represents a 20.7% year‑over‑year rise and translates into a 12% increase when measured in U.S. dollars, underscoring sustained demand for its AI‑driven revenue‑cycle management solutions.
Profit after tax (PAT) climbed to INR 1,937 million, a 27.8% YoY gain that left PAT as 21.7% of revenue. Adjusted PAT, which excludes one‑off items, reached INR 2,153 million – a 28.0% YoY increase – and stood at 24.1% of revenue.
“We’ve delivered a solid first quarter that demonstrates the resilience of our business model, built on strong client trust, operational efficiency, and a scalable care‑enablement platform,” said Sachin K. Gupta, Founder and Global CEO of IKS Health. Gupta added that the recent acquisition of TruBridge, a rural‑hospital‑focused provider of electronic‑health‑record and revenue‑cycle services, expands the company’s capabilities and deepens its reach into community hospitals.
Group Chief Financial Officer Nithya Balasubramanian highlighted the role of disciplined cost management and capital efficiency in driving the results. “We closed Q1 FY27 with robust financial results, delivering 21% YoY revenue growth and a 28% YoY increase in PAT. Our priority for the remainder of the fiscal year remains clear: protecting our margins while investing prudently in strategic capabilities that secure long‑term value,” she said.
Key financial highlights for the quarter were:
Revenue: INR 8,936 million, up 20.7% YoY EBITDA: INR 2,949 million, 33% of revenue, up 24% YoY PAT: INR 1,937 million, 21.7% of revenue, up 27.8% YoY Adjusted PAT: INR 2,153 million, 24.1% of revenue, up 28.0% YoY
In addition to the numbers, IKS Health earned several industry recognitions. A U.S. patent was granted for its proprietary Engagement Learning Engine, an AI‑driven “Awareness‑Ability‑Willingness” behavioral model that powers patient‑access solutions such as MyCareHub. The company was named a Titan CEO in the 2026 Dallas‑Fort Worth Titan 100 list, and its CFO, Nithya Balasubramanian, received the Best CFO in Healthcare award at the 2026 CFO & Finance Strategy Excellence Awards. IKS Health also earned the FE HR Award for Excellence in Onboarding and Role Enablement and the American Medical Group Association Distinguished Corporate Partner Award.
The acquisition of TruBridge closed on 9 July 2026 for $557 million, following an announcement in April 2026. The deal brings TruBridge’s rural‑hospital‑focused electronic‑health‑record and revenue‑cycle capabilities into IKS Health’s AI‑powered platform, allowing the company to expand its service footprint and deepen relationships with community hospitals.
With a 46% compound annual growth rate in PAT over the past decade, IKS Health’s latest results reinforce its trajectory of profitable growth. Investors and analysts will be watching the company’s performance in the remaining quarters of FY27, its ability to integrate TruBridge’s operations, and its continued expansion into rural and community health systems.
IKS Health’s CEO reiterated a focus on margin protection while investing in strategic capabilities that secure long‑term value. The next earnings release is expected in the fourth quarter of FY27, where analysts will look for continued revenue growth, margin stability, and the impact of the TruBridge integration.
In summary, IKS Health reported strong first‑quarter results, highlighted by significant revenue and PAT growth, a successful acquisition that expands its rural‑hospital footprint, and several industry awards that underscore its leadership in AI‑driven healthcare solutions.
